Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phospholipid binding improves plasma survival of factor VIII.

× No keyword cloud information.

23 in total

1. Receptor versus non-receptor mediated clearance of liposomes.

Authors:
Journal: Adv Drug Deliv Rev Date: 1998-06-08 Impact factor: 15.470

Review 2. Clearance mechanisms of von Willebrand factor and factor VIII.

Authors: P J Lenting; C J M VAN Schooten; C V Denis
Journal: J Thromb Haemost Date: 2007-04-07 Impact factor: 5.824

3. Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs.

Authors: Gary E Gilbert; Randal J Kaufman; Andrew A Arena; Hongzhi Miao; Steven W Pipe
Journal: J Biol Chem Date: 2001-11-06 Impact factor: 5.157

4. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.

Authors: E Saenko; A Sarafanov; N Greco; M Shima; K Loster; H Schwinn; D Josic
Journal: J Chromatogr A Date: 1999-08-06 Impact factor: 4.759

Review 5. Clearance of von Willebrand factor.

Authors: Cécile V Denis; Olivier D Christophe; Beatrijs D Oortwijn; Peter J Lenting
Journal: Thromb Haemost Date: 2008-02 Impact factor: 5.249

Review 6. Hemophilia A--from basic science to clinical practice.

Authors: Jens Klinge; Natalya M Ananyeva; Charlotte A E Hauser; Evgueni L Saenko
Journal: Semin Thromb Hemost Date: 2002-06 Impact factor: 4.180

Review 7. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.

Authors: Trevor W Barrowcliffe; Sanjeev Raut; Dawn Sands; Anthony R Hubbard
Journal: Semin Thromb Hemost Date: 2002-06 Impact factor: 4.180

8. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors: A Gabizon; D Papahadjopoulos
Journal: Proc Natl Acad Sci U S A Date: 1988-09 Impact factor: 11.205

9. A role for the C2 domain of factor VIII in binding to von Willebrand factor.

Authors: E L Saenko; M Shima; K J Rajalakshmi; D Scandella
Journal: J Biol Chem Date: 1994-04-15 Impact factor: 5.157

10. Interaction of factor VIII with phospholipids: role of composition and negative charge.

Authors: G Kemball-Cook; T W Barrowcliffe
Journal: Thromb Res Date: 1992-07-01 Impact factor: 3.944

14 in total

Review 1. Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.

Authors: Johannes Oldenburg; Sébastien Lacroix-Desmazes; David Lillicrap
Journal: Haematologica Date: 2015-02 Impact factor: 9.941

2. Native-like aggregates of factor VIII are immunogenic in von Willebrand factor deficient and hemophilia a mice.

Authors: Dipak S Pisal; Matthew P Kosloski; C Russell Middaugh; Richard B Bankert; Sathy V Balu-Iyer
Journal: J Pharm Sci Date: 2012-03-02 Impact factor: 3.534

3. Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice.

Authors: Matthew P Kosloski; Dipak S Pisal; Donald E Mager; Sathy V Balu-Iyer
Journal: Biopharm Drug Dispos Date: 2014-01-02 Impact factor: 1.627

4. Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes.

Authors: Aaron Peng; Dipak S Pisal; Amy Doty; Sathy V Balu-Iyer
Journal: Chem Phys Lipids Date: 2011-10-17 Impact factor: 3.329

5. Phospholipid binding lowers immunogenicity of human recombinant factor VIII in von Willebrand factor knockout mice.

Authors: D S Pisal; S V Balu-Iyer
Journal: Thromb Haemost Date: 2011-04-07 Impact factor: 5.249

6. PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.

Authors: Aaron Peng; Matthew P Kosloski; Genki Nakamura; Hong Ding; Sathy V Balu-Iyer
Journal: AAPS J Date: 2011-12-16 Impact factor: 4.009

7. Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Authors: Matthew P Kosloski; Krithika A Shetty; Hironao Wakabayashi; Philip J Fay; Sathy V Balu-Iyer
Journal: AAPS J Date: 2014-06-17 Impact factor: 4.009

Review 8. Novel therapies and current clinical progress in hemophilia A.

Authors: Pauline Balkaransingh; Guy Young
Journal: Ther Adv Hematol Date: 2017-12-28

9. Soy phosphatidylinositol containing nanoparticle prolongs hemostatic activity of B-domain deleted factor VIII in hemophilia A mice.

Authors: Krithika A Shetty; Matthew P Kosloski; Donald E Mager; Sathy V Balu-Iyer
Journal: J Pharm Sci Date: 2014-04-02 Impact factor: 3.534

10. Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice.

Authors: Kellie R Machlus; Feng-Chang Lin; Alisa S Wolberg
Journal: Blood Date: 2011-08-09 Impact factor: 22.113